151 related articles for article (PubMed ID: 15225622)
41. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
42. Pathological significance of ganglioside clusters in Alzheimer's disease.
Yanagisawa K
J Neurochem; 2011 Mar; 116(5):806-12. PubMed ID: 21214549
[TBL] [Abstract][Full Text] [Related]
43. Interaction between amyloid beta-protein aggregates and membranes.
Kakio A; Yano Y; Takai D; Kuroda Y; Matsumoto O; Kozutsumi Y; Matsuzaki K
J Pept Sci; 2004 Oct; 10(10):612-21. PubMed ID: 15526710
[TBL] [Abstract][Full Text] [Related]
44. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
45. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
46. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
Huang Y
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
[TBL] [Abstract][Full Text] [Related]
47. [Effects of oxidative stress inducers, neurotoxins, and ganglioside GM1 on Na+, K+-ATPase in PC12 and brain synaptosomes].
Zakharova IO; Sokolova TV; Furaev VV; Rychkova MP; Avrova NF
Zh Evol Biokhim Fiziol; 2007; 43(2):148-54. PubMed ID: 17674707
[TBL] [Abstract][Full Text] [Related]
48. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA
J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223
[TBL] [Abstract][Full Text] [Related]
49. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice.
Huebbe P; Jofre-Monseny L; Boesch-Saadatmandi Ch; Minihane AM; Rimbach G
J Physiol Pharmacol; 2007 Dec; 58(4):683-98. PubMed ID: 18195481
[TBL] [Abstract][Full Text] [Related]
50. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.
Grootendorst J; Bour A; Vogel E; Kelche C; Sullivan PM; Dodart JC; Bales K; Mathis C
Behav Brain Res; 2005 Apr; 159(1):1-14. PubMed ID: 15794991
[TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein E and Alzheimer disease.
Huang Y
Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
[TBL] [Abstract][Full Text] [Related]
52. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN
Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242
[TBL] [Abstract][Full Text] [Related]
53. A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice.
Blain JF; Sullivan PM; Poirier J
Neurobiol Dis; 2006 Mar; 21(3):505-14. PubMed ID: 16171999
[TBL] [Abstract][Full Text] [Related]
54. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
55. Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside.
Kurganov B; Doh M; Arispe N
Peptides; 2004 Feb; 25(2):217-32. PubMed ID: 15063003
[TBL] [Abstract][Full Text] [Related]
56. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
57. Leptin inhibits amyloid β-protein fibrillogenesis by decreasing GM1 gangliosides on the neuronal cell surface through PI3K/Akt/mTOR pathway.
Yamamoto N; Tanida M; Kasahara R; Sobue K; Suzuki K
J Neurochem; 2014 Nov; 131(3):323-32. PubMed ID: 25039425
[TBL] [Abstract][Full Text] [Related]
58. Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein.
Yamamoto N; Hasegawa K; Matsuzaki K; Naiki H; Yanagisawa K
J Neurochem; 2004 Jul; 90(1):62-9. PubMed ID: 15198667
[TBL] [Abstract][Full Text] [Related]
59. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.
Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K
Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171
[TBL] [Abstract][Full Text] [Related]
60. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
